Efficacy and Safety of Intranasal Cenegermin in Adult Participants With Non-Arteritic Anterior Ischemic Optic Neuropathy (NAION)
Clinical trial NCT07453888 · RECRUITING
Trial details
- NCT number
- NCT07453888
- Sponsor
- Dompé Farmaceutici S.p.A
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-07-01
- Primary completion
- 2027-09-01
- Enrollment
- 272
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.